Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbie B Mailliard

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Plos One|May 8, 2014
Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201)John E McKinnon, Robbie B Mailliard, Susan Swindells, et al.
Mbio|June 2, 2016
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T CellsKellie N Smith, Robbie B Mailliard, Paolo A Piazza, et al.
Plos Pathogens|August 10, 2019
CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infectionKai Qin, Sushma Boppana, Victor Y Du, et al.
Journal of Clinical Immunology|May 24, 2025
Complete CD16A Deficiency and Defective NK Cell Function in a Man Living with HIVWeiying Zhang, Alan F Scott, David W Mohr, et al.
The Journal of Clinical Investigation|April 7, 2026
HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohortKatherine Cascino, Thomas Liechti, Eric C Seaberg, et al.
Virology|August 6, 2024
Nef defect attenuates HIV viremia and immune dysregulation in the bone marrow-liver-thymus-spleen (BLTS) humanized mouse modelShivkumar Biradar, Yash Agarwal, Antu Das, et al.
Nature Medicine|May 30, 2017
Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4<sup>+</sup> T cellsAnwesha Sanyal, Robbie B Mailliard, Charles R Rinaldo, et al.
Acta Biomaterialia|November 15, 2025
Harnessing albumin as a carrier for the delivery of anti-HIV drugs to the lymphatic systemZiqian Zhang, Yixian Huang, Raymond E West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
Pancreatic cancer organoids recapitulate chemotherapy response and identify a potent cytotoxic T cell populationRenee R Anderko, Alexandra E Bowman, Praneel Murthy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 31, 2013
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trialBenigno Rodriguez, David M Asmuth, Roy M Matining, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Plos One|May 8, 2014
Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201)John E McKinnon, Robbie B Mailliard, Susan Swindells, et al.
Mbio|June 2, 2016
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T CellsKellie N Smith, Robbie B Mailliard, Paolo A Piazza, et al.
Plos Pathogens|August 10, 2019
CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infectionKai Qin, Sushma Boppana, Victor Y Du, et al.
Journal of Clinical Immunology|May 24, 2025
Complete CD16A Deficiency and Defective NK Cell Function in a Man Living with HIVWeiying Zhang, Alan F Scott, David W Mohr, et al.
The Journal of Clinical Investigation|April 7, 2026
HIV causes global B-cell dysregulation and restricts HBV-specific B-cell development in an incident HBV cohortKatherine Cascino, Thomas Liechti, Eric C Seaberg, et al.
Virology|August 6, 2024
Nef defect attenuates HIV viremia and immune dysregulation in the bone marrow-liver-thymus-spleen (BLTS) humanized mouse modelShivkumar Biradar, Yash Agarwal, Antu Das, et al.
Nature Medicine|May 30, 2017
Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4<sup>+</sup> T cellsAnwesha Sanyal, Robbie B Mailliard, Charles R Rinaldo, et al.
Acta Biomaterialia|November 15, 2025
Harnessing albumin as a carrier for the delivery of anti-HIV drugs to the lymphatic systemZiqian Zhang, Yixian Huang, Raymond E West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
Pancreatic cancer organoids recapitulate chemotherapy response and identify a potent cytotoxic T cell populationRenee R Anderko, Alexandra E Bowman, Praneel Murthy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 31, 2013
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trialBenigno Rodriguez, David M Asmuth, Roy M Matining, et al.
Pageof 6